{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:42:15Z","timestamp":1792010535858,"version":"4.4.0"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.mrrev.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T01:46:57Z","timestamp":1504662417000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Carcinogenic potential of sanguinarine, a phytochemical used in \u2018therapeutic\u2019 black salve and mouthwash"],"prefix":"10.1016","volume":"774","author":[{"given":"Andrew","family":"Croaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham J.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Pyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Anoopkumar-Dukie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilim","family":"Simanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mrrev.2017.09.001_bib0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2174\/138920011798062328","article-title":"Toxicities by herbal medicines with emphasis to traditional Chinese medicine","volume":"12","author":"Efferth","year":"2011","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1556-4029.2009.01252.x","article-title":"A review of the potential forensic significance of traditional herbal medicines","volume":"55","author":"Byard","year":"2010","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0015","series-title":"Molecular Biology of Mutagens and Carcinogens","author":"Singer","year":"2012"},{"issue":"7","key":"10.1016\/j.mrrev.2017.09.001_bib0020","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjmed.2003.10.036","article-title":"Commonly used herbal medicines in the United States: a review","volume":"116","author":"Bent","year":"2004","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1515\/reveh-2014-0041","article-title":"Skin cancer: role of ultraviolet radiation in carcinogenesis","volume":"29","author":"Mancebo","year":"2014","journal-title":"Rev. Environ. Health"},{"issue":"8","key":"10.1016\/j.mrrev.2017.09.001_bib0030","first-page":"1727","article-title":"A genetic explanation of Slaughter\u2019s concept of field cancerization evidence and clinical implications","volume":"63","author":"Braakhuis","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2017\/9184034","article-title":"A review of black salve: cancer specificity, cure, and cosmesis","volume":"2017","author":"Croaker","year":"2017","journal-title":"Evid.-Based Complement. Alternat. Med."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5826\/dpc.0403a16","article-title":"Application of black salve to a thin melanoma that subsequently progressed to metastatic melanoma: a case study","volume":"4","author":"Sivyer","year":"2014","journal-title":"Dermatol. Pract. Concept."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/DER.0b013e31826e45a3","article-title":"Black salve as self-treatment for cutaneous squamous cell carcinoma","volume":"23","author":"Ma","year":"2012","journal-title":"Dermatitis"},{"issue":"7","key":"10.1016\/j.mrrev.2017.09.001_bib0050","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bjps.2007.10.090","article-title":"Death from metastatic basal cell carcinoma: herbal remedy or just unlucky?","volume":"61","author":"Laub","year":"2008","journal-title":"J. Plast Reconstr. Aesthet. Surg."},{"issue":"9","key":"10.1016\/j.mrrev.2017.09.001_bib0055","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/ijms17091414","article-title":"Sanguinaria canadensis: traditional medicine, phytochemical composition, biological activities and current uses","volume":"17","author":"Croaker","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1079-2104(99)70296-9","article-title":"Leukoplakia of the maxillary vestibule \u2014 an association with Viadent?","volume":"87","author":"Damm","year":"1999","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12029-012-9458-2","article-title":"Association of mustard oil as cooking media with carcinoma of the gallbladder","volume":"44","author":"Dixit","year":"2013","journal-title":"J. Gastrointest. Cancer"},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.toxlet.2008.01.009","article-title":"A decisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids","volume":"177","author":"Kaminskyy","year":"2008","journal-title":"Toxicol. Lett."},{"issue":"1 A","key":"10.1016\/j.mrrev.2017.09.001_bib0075","first-page":"461","article-title":"Micronucleus formation in human lymphocytes and in the metabolically competent human hepatoma cell line hep-G2: results with 15 naturally occurring substances","volume":"21","author":"Kevekordes","year":"2001","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cbi.2010.07.023","article-title":"Potentiation of tumour promotion by topical application of argemone oil\/isolated sanguinarine alkaloid in a model of mouse skin carcinogenesis","volume":"188","author":"Ansari","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0085","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1751-1097.2007.00156.x","article-title":"Protective effect of sanguinarine on ultraviolet B-mediated damages in SKH-1 hairless mouse skin: implications for prevention of skin cancer","volume":"83","author":"Ahsan","year":"2007","journal-title":"Photochem. Photobiol."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/07391102.2002.10506864","article-title":"Influence of DNA structures on the conversion of sanguinarine alkanolamine form to iminium form","volume":"20","author":"Maiti","year":"2002","journal-title":"J. Biomol. Struct. Dynam."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jmr.300030106","article-title":"Sequence-selective, pH-dependent binding to DNA of benzophenanthridine alkaloids","volume":"3","author":"Bajaj","year":"1990","journal-title":"J. Mol. Recognit."},{"issue":"1\u20133","key":"10.1016\/j.mrrev.2017.09.001_bib0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molstruc.2008.01.016","article-title":"Energetics of the binding of phototoxic and cytotoxic plant alkaloid sanguinarine to DNA: isothermal titration calorimetric studies","volume":"889","author":"Adhikari","year":"2008","journal-title":"J. Mol. Struct."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bpc.2005.04.009","article-title":"Interaction of anticancer drug mitoxantrone with DNA analyzed by electrochemical and spectroscopic methods","volume":"116","author":"Li","year":"2005","journal-title":"Biophys. Chem."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0110","first-page":"2","article-title":"Correlation of the cytotoxic activity of four different alkaloids: from Chelidonium majus (greater celandine), with their DNA intercalating properties and ability to induce breaks in the DNA of NK\/Ly murine lymphoma cells","volume":"1","author":"Kaminskyy","year":"2006","journal-title":"Central Eur. J. Biol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jdermsci.2011.01.006","article-title":"Benzo [c] phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status","volume":"62","author":"Hammerova","year":"2011","journal-title":"J. Dermatol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.mrrev.2017.09.001_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mrfmmm.2007.03.014","article-title":"Genotoxicity of non-covalent interactions: DNA intercalators","volume":"623","author":"Ferguson","year":"2007","journal-title":"Mutat. Res."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.leu.2401021","article-title":"Secondary acute leukemia and myelodysplastic syndrome with 11 q23 abnormalities. EU Concerted Action 11 q23 Workshop","volume":"12","author":"Secker-Walker","year":"1998","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mpo.1125","article-title":"Leukemias related to treatment with DNA topoisomerase II inhibitors*","volume":"36","author":"Felix","year":"2001","journal-title":"Med. Pediatr. Oncol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0014-5793(82)80152-X","article-title":"Sanguinarine: a monofunctional intercalating alkaloid","volume":"142","author":"Maiti","year":"1982","journal-title":"FEBS Lett."},{"issue":"16","key":"10.1016\/j.mrrev.2017.09.001_bib0140","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1016\/j.bmc.2006.05.012","article-title":"DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidine","volume":"14","author":"Bai","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0145","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jps.2600670532","article-title":"Analysis of binding of daunorubicin and doxorubicin to DNA using computerized curve\u00a9\\fitting procedures","volume":"67","author":"Byrn","year":"1978","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.mrrev.2017.09.001_bib0150","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0968-0896(01)00092-X","article-title":"Solution chemistry and DNA binding properties of MEN 10755, a novel disaccharide analogue of doxorubicin","volume":"9","author":"Messori","year":"2001","journal-title":"Bioorganic Med. Chem."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tips.2010.12.002","article-title":"Free radicals and antioxidants\u2014quo vadis?","volume":"32","author":"Halliwell","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.mrrev.2017.09.001_bib0160","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/10408444.2015.1074159","article-title":"Free radicals and related reactive species as mediators of tissue injury and disease: implications for health","volume":"45","author":"Kehrer","year":"2015","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.pharmtox.44.101802.121851","article-title":"The role of oxidative stress in carcinogenesis","volume":"44","author":"Klaunig","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.mrrev.2017.09.001_bib0170","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/carcin\/18.12.2379","article-title":"Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation","volume":"18","author":"Kvam","year":"1997","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.mrrev.2017.09.001_bib0175","first-page":"1247","article-title":"UV-induced reactive oxygen species in photocarcinogenesis and photoaging","volume":"378","author":"Scharffetter-Kochanek","year":"1997","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000064535","article-title":"Photocarcinogenesis: UVA vs: UVB radiation","volume":"15","author":"de Gruijl","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0185","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.freeradbiomed.2015.10.404","article-title":"ROS-dependent activation of autophagy is a critical mechanism for the induction of anti-glioma effect of sanguinarine","volume":"89","author":"Pallichankandy","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0190","doi-asserted-by":"crossref","first-page":"e63425","DOI":"10.1371\/journal.pone.0063425","article-title":"Apoptosis induction of human bladder cancer cells by sanguinarine through reactive oxygen species-mediated up-regulation of early growth response gene-1","volume":"8","author":"Han","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.mrrev.2017.09.001_bib0195","doi-asserted-by":"crossref","first-page":"22355","DOI":"10.18632\/oncotarget.7971","article-title":"Noninvasive bioluminescence imaging of the dynamics of sanguinarine induced apoptosis via activation of reactive oxygen species","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.abb.2008.05.019","article-title":"Production of hydrogen peroxide and redox cycling can explain how sanguinarine and chelerythrine induce rapid apoptosis","volume":"477","author":"Matkar","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.mrrev.2017.09.001_bib0205","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/17425250903042318","article-title":"Physicochemical drug properties associated with in vivo toxicological outcomes: a review","volume":"5","author":"Price","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0210","series-title":"Mechanism of Action of Potential Anticancer Drugs","author":"Matkar","year":"2008"},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0215","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3892\/or.2015.4054","article-title":"Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and endoplasmic reticulum stress","volume":"34","author":"Gu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0220","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.semcdb.2007.09.003","article-title":"The endoplasmic reticulum and the unfolded protein response","volume":"18","author":"Malhotra","year":"2007","journal-title":"Semin. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.mrrev.2017.09.001_bib0225","doi-asserted-by":"crossref","first-page":"a004424","DOI":"10.1101\/cshperspect.a004424","article-title":"ER stress and its functional link to mitochondria: role in cell survival and death","volume":"3","author":"Malhotra","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0230","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.1038\/cddis.2013.453","article-title":"Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells","volume":"4","author":"Sanchez-Lopez","year":"2013","journal-title":"Cell. Death. Dis."},{"issue":"12","key":"10.1016\/j.mrrev.2017.09.001_bib0235","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1089\/ars.2007.1782","article-title":"Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?","volume":"9","author":"Malhotra","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"7","key":"10.1016\/j.mrrev.2017.09.001_bib0240","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1158\/0008-5472.CAN-05-4033","article-title":"Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity","volume":"66","author":"Huh","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1078-1439(02)00208-9","article-title":"Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen","volume":"21","author":"Wang","year":"2003","journal-title":"Urol. Oncol.: Semin. Orig. Investig."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0250","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/1523-1747.ep12343523","article-title":"Constitutive nitric oxide synthase is present in normal human keratinocytes","volume":"106","author":"Baudouin","year":"1996","journal-title":"J. Invest. Dermatol."},{"issue":"30","key":"10.1016\/j.mrrev.2017.09.001_bib0255","doi-asserted-by":"crossref","first-page":"21277","DOI":"10.1016\/S0021-9258(19)36601-3","article-title":"Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing","volume":"267","author":"Heck","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/1523-1747.ep12343428","article-title":"Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms","volume":"106","author":"Wang","year":"1996","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/1523-1747.ep12371744","article-title":"Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin","volume":"102","author":"Shindo","year":"1994","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0270","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1046\/j.0022-202x.2001.01469.x","article-title":"Aging- and photoaging-dependent changes of enzymic and nonenzymic antioxidants in the epidermis and dermis of human skin in vivo","volume":"117","author":"Rhie","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"1\u20133","key":"10.1016\/j.mrrev.2017.09.001_bib0275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-4274(01)00430-1","article-title":"Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaternary benzocphenanthridine alkaloids","volume":"125","author":"Ulrichova","year":"2001","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0280","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00280-003-0609-9","article-title":"Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion","volume":"51","author":"Debiton","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"9","key":"10.1016\/j.mrrev.2017.09.001_bib0285","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/jm00141a019","article-title":"Inhibition of liver alanine aminotransferase activity by some benzophenanthridine alkaloids","volume":"24","author":"Walterova","year":"1981","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cbi.2007.12.006","article-title":"Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines","volume":"172","author":"Matkar","year":"2008","journal-title":"Chem. Biol. Interact."},{"issue":"54","key":"10.1016\/j.mrrev.2017.09.001_bib0295","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1038\/sj.onc.1203249","article-title":"More than one way to die: apoptosis, necrosis and reactive oxygen damage","volume":"18","author":"Fiers","year":"1999","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0300","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/carcin\/21.3.361","article-title":"Oxyradicals and DNA damage","volume":"21","author":"Marnett","year":"2000","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.mrrev.2017.09.001_bib0305","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1096\/fj.02-0752rev","article-title":"Oxidative DNA damage: mechanisms, mutation, and disease","volume":"17","author":"Cooke","year":"2003","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0310","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0959-8049(95)00531-5","article-title":"Role of oxygen free radicals in cancer development","volume":"32","author":"Dreher","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"4685","key":"10.1016\/j.mrrev.2017.09.001_bib0315","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.2981433","article-title":"Prooxidant states and tumor promotion","volume":"227","author":"Cerutti","year":"1985","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0009-2797(02)00038-8","article-title":"DNA adduct formation from quaternary benzo [c] phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the P-32-postlabeling technique","volume":"140","author":"Stiborova","year":"2002","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0325","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/tx960158q","article-title":"Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack","volume":"10","author":"Lloyd","year":"1997","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/tx00001a010","article-title":"Identification of adducts formed by reaction of guanine nucleosides with malondialdehyde and structurally related aldehydes","volume":"1","author":"Basu","year":"1988","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0335","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fct.2005.07.006","article-title":"Investigation of sanguinarine and chelerythrine effects on CYP1 A1 expression and activity in human hepatoma cells","volume":"44","author":"Zdarilova","year":"2006","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.fct.2003.08.007","article-title":"Sanguinarine and chelerythrine: assessment of safety on pigs in ninety days feeding experiment","volume":"42","author":"Kosina","year":"2004","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0345","doi-asserted-by":"crossref","DOI":"10.1080\/10408440903164155","article-title":"Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization","author":"Jarabek","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"issue":"8","key":"10.1016\/j.mrrev.2017.09.001_bib0350","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/10408440903164163","article-title":"Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage","volume":"39","author":"Himmelstein","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0355","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/tx700408t","article-title":"Biomarkers in toxicology and risk assessment: informing critical dose\u2013response relationships","volume":"21","author":"Swenberg","year":"2007","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0360","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx00030a003","article-title":"DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment","volume":"5","author":"Poirier","year":"1992","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0365","first-page":"196","article-title":"Influence of 3-methylcholanthrene pretreatment on sanguinarine toxicity in mice","volume":"42","author":"Williams","year":"2000","journal-title":"Vet. Hum. Toxicol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0031-6997(25)00051-1","article-title":"Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis","volume":"34","author":"Pelkonen","year":"1982","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0375","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/PL00002973","article-title":"The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals","volume":"61","author":"Denison","year":"1998","journal-title":"Bull. Environ. Contam. Toxicol."},{"issue":"11","key":"10.1016\/j.mrrev.2017.09.001_bib0380","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1135\/cccc19862626","article-title":"Reduction of quaternary benzophenanthridine alkaloids by NADH and NADPH","volume":"51","author":"Kov\u00e1\u0159","year":"1986","journal-title":"Collect. Czech. Chem. Commun."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0385","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchromb.2005.10.030","article-title":"A liquid chromatographic-mass spectrometric evidence of dihydrosanguinarine as a first metabolite of sanguinarine transformation in rat","volume":"830","author":"Psotova","year":"2006","journal-title":"J. Chromatogr. B-Anal. Technol. Biomed. Life Sci."},{"issue":"15\u201316","key":"10.1016\/j.mrrev.2017.09.001_bib0390","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jchromb.2011.03.023","article-title":"Identification of benzo [c] phenanthridine metabolites in human hepatocytes by liquid chromatography with electrospray ion-trap and quadrupole time-of-flight mass spectrometry","volume":"879","author":"Kosina","year":"2011","journal-title":"J. Chromatogr. B-Anal. Technol. Biomed. Life Sci."},{"issue":"7","key":"10.1016\/j.mrrev.2017.09.001_bib0395","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.fct.2008.04.013","article-title":"The toxicity and pharmacokinetics of dihydrosanguinarine in rat: a pilot study","volume":"46","author":"Vrublova","year":"2008","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0400","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.onc.1206063","article-title":"hTERT associates with human telomeres and enhances genomic stability and DNA repair","volume":"22","author":"Sharma","year":"2003","journal-title":"Oncogene"},{"issue":"29","key":"10.1016\/j.mrrev.2017.09.001_bib0405","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3748\/wjg.15.3603","article-title":"Transcriptional down regulation of hTERT and senescence induction in HepG2 cells by chelidonine","volume":"15","author":"Noureini","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0410","first-page":"121","article-title":"Investigation of telomerase activity and HTERT gene expression in MCF7 cells treated with papaverine","volume":"20","author":"Kazemi","year":"2013","journal-title":"J. Sabzevar Univ. Med. Sci."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0415","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/cb300096g","article-title":"Spectroscopic, molecular modeling, and NMR-spectroscopic investigation of the binding mode of the natural alkaloids berberine and sanguinarine to human telomeric G-quadruplex DNA","volume":"7","author":"Bessi","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0420","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0425","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Res."},{"issue":"1\u20133","key":"10.1016\/j.mrrev.2017.09.001_bib0430","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejphar.2012.05.039","article-title":"The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages","volume":"689","author":"Niu","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0435","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2013.01.009","article-title":"Protective effect of sanguinarine against acetic acid-induced ulcerative colitis in mice","volume":"267","author":"Niu","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0440","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cbi.2005.10.105","article-title":"Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappa B in HeLa cells","volume":"159","author":"Dvorak","year":"2006","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.mrrev.2017.09.001_bib0445","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/PAT.0000000000000005","article-title":"Histopathological features associated with application of black salve to cutaneous lesions: a series of 16 cases and review of the literature","volume":"45","author":"Leecy","year":"2013","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0450","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindel\u00f6f","year":"2000","journal-title":"Br. J. Dermatol."},{"issue":"25","key":"10.1016\/j.mrrev.2017.09.001_bib0455","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1056\/NEJMcibr054224","article-title":"Immunosuppression: skin cancer, and ultraviolet a radiation","volume":"353","author":"Parrish","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0460","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/1523-1747.ep12504877","article-title":"Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans","volume":"95","author":"Yoshikawa","year":"1990","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0465","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/1097-0142(19950715)76:2<228::AID-CNCR2820760211>3.0.CO;2-N","article-title":"Impaired cell\u00a9\\mediated immunity of apparently normal patients who had multiple skin cancers","volume":"76","author":"Czarnecki","year":"1995","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0470","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.biochem.69.1.419","article-title":"Platelet-activating factor and related lipid mediators","volume":"69","author":"Prescott","year":"2000","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0475","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-8674(93)90666-E","article-title":"cPLA 2 is phosphorylated and activated by MAP kinase","volume":"72","author":"Lin","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0480","first-page":"L73","article-title":"EEC notes for guidance for the testing of medicinal products for their mutagenic potential","year":"1987","journal-title":"Offi. J. Eur. Commun."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0485","article-title":"Note for guidance on genotoxicity: guidance on specific aspects of regulatory genotoxicity test for pharmaceuticals","author":"CPMP\/ICH","year":"1995","journal-title":"International Conference of Harmonisation"},{"issue":"7 Suppl","key":"10.1016\/j.mrrev.2017.09.001_bib0490","first-page":"41","article-title":"Safety of Sanguinaria extract as used in commercial toothpaste and oral rinse products","volume":"56","author":"Frankos","year":"1990","journal-title":"J. Can. Dent. Assoc."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0495","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/rtph.1999.1339","article-title":"Viadent usage and oral leukoplakia: a spurious association","volume":"30","author":"Munro","year":"1999","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0500","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1383-5718(99)00141-2","article-title":"SOS induction of selected naturally occurring substances in Escherichia coli (SOS chromotest)","volume":"445","author":"Kevekordes","year":"1999","journal-title":"Mutat. Res.-Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0505","series-title":"The SOS Chromotest: a Review","first-page":"p. 235","author":"Quillardet","year":"1993"},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0510","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cellbi.2007.09.004","article-title":"Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells","volume":"32","author":"Kaminskyy","year":"2008","journal-title":"Cell Biol. Int."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0515","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10565-006-0109-x","article-title":"The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine","volume":"22","author":"Malikova","year":"2006","journal-title":"Cell Biol. Toxicol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0520","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tiv.2007.08.023","article-title":"Apoptogenic activity of two benzophenanthridine alkaloids from Chelidonium majus L. does not correlate with their DNA damaging effects","volume":"22","author":"Philchenkov","year":"2008","journal-title":"Toxicol. In Vitro"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0525","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5507\/bp.2006.001","article-title":"Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis","volume":"150","author":"Malikova","year":"2006","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0530","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/mutage\/gei033","article-title":"The in vivo comet assay: use and status in genotoxicity testing","volume":"20","author":"Brendler-Schwaab","year":"2005","journal-title":"Mutagenesis"},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0535","first-page":"1524","article-title":"Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells","volume":"6","author":"Ahmad","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0540","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11101-013-9290-8","article-title":"Antitumour activities of sanguinarine and related alkaloids","volume":"13","author":"Slaninova","year":"2014","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0545","first-page":"59","article-title":"Summary report on the performance of the assays for DNA damage","volume":"5","author":"Williams","year":"1985","journal-title":"Prog. Mutat. Res."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0550","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/mutage\/6.5.399","article-title":"Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens\/carcinogens","volume":"6","author":"Natarajan","year":"1991","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0555","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mrgentox.2014.10.008","article-title":"IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk","volume":"783","author":"MacGregor","year":"2015","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0560","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrgentox.2006.10.004","article-title":"Strategy for genotoxicity testing\u2014metabolic considerations","volume":"627","author":"Ku","year":"2007","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0565","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02977789","article-title":"Induction of phase I, II and III drug metabolism\/transport by xenobiotics","volume":"28","author":"Xu","year":"2005","journal-title":"Arch. Pharmacal Res."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2005.02.004","article-title":"Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: I. Sensitivity, specificity and relative predictivity","volume":"584","author":"Kirkland","year":"2005","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0575","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yrtph.2005.11.003","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0580","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yrtph.2005.10.004","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0585","series-title":"Guidance on a Strategy for Testing of Chemicals for Mutagenicity","author":"COM (United Kingdom Committee on Mutagenicity of Chemicals in Food, C.P.a.t.E","year":"2000"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0590","series-title":"Guidance for Industry and Review Staff Recommended Approaches to Integration of Genetic Toxicology Study Results","author":"FDA","year":"2006"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0595","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/mutage\/18.1.45","article-title":"Recommendations for conducting the in vivo alkaline Comet assay","volume":"18","author":"Hartmann","year":"2003","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0600","doi-asserted-by":"crossref","first-page":"p. 45","DOI":"10.1016\/j.mrgentox.2015.04.010","article-title":"JaCVAM-organized international validation study of the in vivo rodent alkaline comet assay for detection of genotoxic carcinogens: II. Summary of definitive validation study results","volume":"786","author":"Uno","year":"2015","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0605","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fct.2004.09.005","article-title":"In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice","volume":"43","author":"Ansari","year":"2005","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0610","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ijc.20319","article-title":"Unequivocal evidence of genotoxic potential of argemone oil in mice","volume":"112","author":"Ansari","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0615","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ijc.21234","article-title":"Correlation of DNA damage in epidemic dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice","volume":"117","author":"Das","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0620","first-page":"1515","article-title":"Sanguiritrin-novyi lekarstvenyi preparat protivomikrobnogo deistviya","volume":"16","author":"Vichkanova","year":"1982","journal-title":"Khim.-Farm. Zh."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0625","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5507\/bp.2008.005","article-title":"Macleaya cordata extract and Sangrovit genotoxicity. Assessment in vivo","volume":"152","author":"Stiborova","year":"2008","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0630","article-title":"Estimating the carcinogenic potency of chemicals from the in vivo micronucleus test","author":"Soeteman-Hern\u00e1ndez","year":"2015","journal-title":"Mutagenesis"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0635","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0027-5107(00)00117-2","article-title":"In vivo rodent micronucleus assay: protocol, conduct and data interpretation","volume":"455","author":"Krishna","year":"2000","journal-title":"Mutat. Res.\/Fund. Mol. Mech. Mutagen."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0640","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mrgentox.2004.06.004","article-title":"Sanguinarine: an evaluation of in vivo cytogenetic activity","volume":"563","author":"Das","year":"2004","journal-title":"Mutat. Res.-Genet. Toxicol. Environ. Mutagen."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0645","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-1110(81)90003-8","article-title":"Sister-chromatid exchanges: a report of the GENE-TOX program","volume":"87","author":"Latt","year":"1981","journal-title":"Mutat. Res.\/Rev. Genet. Toxicol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0650","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1110(81)90030-0","article-title":"Mammalian in vivo and in vitro cytogenetic assays: a report of the US EPA's Gene-Tox Program","volume":"87","author":"Preston","year":"1981","journal-title":"Mutat. Res.\/Rev. Genet. Toxicol."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0655","series-title":"The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons","first-page":"p. 171","article-title":"DNA damage and mutagenesis induced by polycyclic aromatic hydrocarbons","author":"Besaratinia","year":"2005"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0660","series-title":"In Vivo Detection of Ribozyme Cleavage Products and RNA Structure by Use of Terminal Transferase-dependent PCR, in Ribozymes and SiRNA Protocols","first-page":"p. 109","author":"Chen","year":"2004"},{"issue":"157","key":"10.1016\/j.mrrev.2017.09.001_bib0665","first-page":"247","article-title":"TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer","author":"Olivier","year":"2003","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0670","series-title":"Spontaneous Neoplastic Lesions and Selected Non-neoplastic Lesions in the Crl: CD BR Rat","first-page":"p. 1","author":"Lang","year":"1992"},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0675","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1752-7325.2002.tb03437.x","article-title":"The association between viadent (R) use and oral leukoplakia \u2014 results of a matched case-control study","volume":"62","author":"Mascarenhas","year":"2002","journal-title":"J. Public Health Dent."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0680","first-page":"161","article-title":"Effects of sanguinaria extract on leucocytes and fibroblasts","volume":"84","author":"Karjalainen","year":"1988","journal-title":"Proc. Finn. Dent. Soc."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0685","first-page":"59","article-title":"Reproductive and developmental toxicological evaluation of sanguinaria extract","volume":"1","author":"Keller","year":"1989","journal-title":"J. Clin. Dent."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0690","first-page":"17","article-title":"Longitudinal evaluation of the effect of sanguinarine on plaque and gingivitis","volume":"38","author":"Palcanis","year":"1989","journal-title":"Gen. Dent."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0695","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/1097-0142(197510)36:4<1386::AID-CNCR2820360430>3.0.CO;2-7","article-title":"Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias","volume":"36","author":"Waldron","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0700","first-page":"157","article-title":"The flow of saliva and its influence on the movement, deposition and removal of drugs administered to the oral cavity","volume":"74","author":"Weatherell","year":"1996","journal-title":"Drugs Pharm. Sci."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0705","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1079-2104(00)70125-9","article-title":"Sanguinaria-associated oral leukoplakia: comparison with other benign and dysplastic leukoplakic lesions","volume":"89","author":"Eversole","year":"2000","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0710","first-page":"608","article-title":"Sanguinaria-related leukoplakia: epidemiologic and clinicopathologic features of a recently described entity","volume":"49","author":"Allen","year":"2000","journal-title":"Gen. Dent."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0715","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1079-2104(99)70256-8","article-title":"Viadent-related leukoplakia\u2014the tip of the iceberg?","volume":"87","author":"Allen","year":"1999","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0720","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.oraloncology.2004.08.008","article-title":"Immunohistochemical assessment of Viadent-associated leukoplakia","volume":"41","author":"Anderson","year":"2005","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0725","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00129039-200003000-00010","article-title":"Paraffin section storage and immunohistochemistry: effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen","volume":"8","author":"Wester","year":"2000","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"9340","key":"10.1016\/j.mrrev.2017.09.001_bib0730","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0735","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-2952(99)00310-X","article-title":"Role of the aromatic hydrocarbon receptor and Ah gene battery in the oxidative stress response, cell cycle control, and apoptosis","volume":"59","author":"Nebert","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0740","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.toxlet.2005.02.007","article-title":"Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues","volume":"158","author":"Karp","year":"2005","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0745","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.toxlet.2005.05.010","article-title":"Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues","volume":"158","author":"Dvorak","year":"2005","journal-title":"Toxicol. Lett."},{"issue":"9","key":"10.1016\/j.mrrev.2017.09.001_bib0750","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.fct.2006.04.016","article-title":"Quaternary benzo [c] phenathridine alkaloids sanguinarine and chelerythrine do not affect transcriptional activity of aryl hydrocarbon receptor: analyses in rat hepatoma cell line H4IIE.luc","volume":"44","author":"Dvo\u0159\u00e1k","year":"2006","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0755","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.toxlet.2004.03.005","article-title":"Involvement of cytochrome p450 1 A in sanguinarine detoxication","volume":"151","author":"Vrba","year":"2004","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0760","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jso.2930280109","article-title":"Primary carcinoma of the gall bladder: a review of a 16\u00a9\\year period at the university hospital","volume":"28","author":"Shukla","year":"1985","journal-title":"J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.mrrev.2017.09.001_bib0765","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.mrrev.2017.09.001_bib0770","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1515::AID-CNCR21>3.0.CO;2-1","article-title":"Risk factors of gallbladder cancer: an international collaborative case\u00a9\\contol study","volume":"78","author":"Serra","year":"1996","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0775","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ije\/18.1.50","article-title":"Gallstone growth, size, and risk of gallbladder cancer: an interracial study","volume":"18","author":"Lowenfels","year":"1989","journal-title":"Int. J. Epidemiol."},{"issue":"17","key":"10.1016\/j.mrrev.2017.09.001_bib0780","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.1983.03340170049027","article-title":"Gallstone size and the risk of gallbladder cancer","volume":"250","author":"Diehl","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0785","series-title":"Tumors of the gallbladder and extrahepatic bile ducts. Atlas of tumor pathology. 2nd series, fascicle 22","author":"Albores-Saavedra","year":"1986"},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0790","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1023\/A:1005564822630","article-title":"Carcinoma of the gallbladder\u2014is it a sequel of typhoid?","volume":"45","author":"Shukla","year":"2000","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0795","first-page":"1209","article-title":"Epidemiology of gallbladder cancer: a synthesis of recent data","volume":"65","author":"Diehl","year":"1980","journal-title":"J. Natl. Cancer Inst."},{"issue":"09","key":"10.1016\/j.mrrev.2017.09.001_bib0800","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S0007114510002229","article-title":"Genotoxic and carcinogenic risks associated with the dietary consumption of repeatedly heated coconut oil","volume":"104","author":"Srivastava","year":"2010","journal-title":"Br. J. Nutr."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0805","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tiv.2005.08.019","article-title":"Genotoxicity and oxidative stress of the mutagenic compounds formed in fumes of heated soybean oil: sunflower oil and lard","volume":"20","author":"Dung","year":"2006","journal-title":"Toxicol. In Vitro"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0810","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0027-5107(98)00015-3","article-title":"Nitro-polycyclic aromatic hydrocarbon contents of fumes from heated cooking oils and prevention of mutagenicity by catechin","volume":"403","author":"Wu","year":"1998","journal-title":"Mutat. Res.\/Fund. Mol. Mech. Mutagen."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0815","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.tiv.2004.01.004","article-title":"Effects of cooking oil fumes on the genotoxicity and oxidative stress in human lung carcinoma (A-549) cells","volume":"18","author":"Wu","year":"2004","journal-title":"Toxicol. In Vitro"},{"issue":"11","key":"10.1016\/j.mrrev.2017.09.001_bib0820","first-page":"498","article-title":"Argemone and mustard seeds","volume":"85","author":"Sanyal","year":"1950","journal-title":"Indian Med. Gaz."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0825","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10408449709089896","article-title":"Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil","volume":"27","author":"Das","year":"1997","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0830","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jat.2550110309","article-title":"Biochemical toxicology of argemone oil: i. effect on hepatic cytochrome P\u00a9\\450 and xenobiotic metabolizing enzymes","volume":"11","author":"Upreti","year":"1991","journal-title":"J. Appl. Toxicol."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0835","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.foodchem.2004.10.012","article-title":"Quantitative evaluation of sanguinarine as an index of argemone oil adulteration in edible mustard oil by high performance thin layer chromatography","volume":"91","author":"Ghosh","year":"2005","journal-title":"Food Chem."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0840","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/ars.2006.1492","article-title":"Adulteration of mustard cooking oil with argemone oil: do Indian food regulatory policies and antioxidant therapy both need revisitation?","volume":"9","author":"Babu","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0845","article-title":"Epidemic dropsy in trans yamuna areas of delhi and UP","volume":"31","author":"Gomber","year":"1994","journal-title":"Indian Pediatr."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0850","first-page":"332","article-title":"The Mexican poppy poisons the Indian mustard facts and figures","volume":"47","author":"Thatte","year":"1999","journal-title":"J. Assoc. Physicians India"},{"issue":"13","key":"10.1016\/j.mrrev.2017.09.001_bib0855","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.ejca.2011.09.026","article-title":"Edible oil adulterants: argemone oil and butter yellow, as aetiological factors for gall bladder cancer","volume":"48","author":"Mishra","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0860","first-page":"263","article-title":"Recommendations for the performance of UDS tests in vitro and in vivo","volume":"312","author":"Madle","year":"1994","journal-title":"Mutat Res.\/Environ. Mutagen. Relat. Sub."},{"issue":"4","key":"10.1016\/j.mrrev.2017.09.001_bib0865","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/em.20176","article-title":"Use of genetic toxicology information for risk assessment","volume":"46","author":"Dearfield","year":"2005","journal-title":"Environ. Mol. Mutagen."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0870","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mrgentox.2006.10.003","article-title":"Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing","volume":"627","author":"Thybaud","year":"2007","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0875","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1383-5718(99)00084-4","article-title":"Study of a rat skin in vivo micronucleus test: data generated by mitomycin C and methyl methanesulfonate","volume":"444","author":"Nishikawa","year":"1999","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0880","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1383-5718(01)00292-3","article-title":"Further evaluation of an in vivo micronucleus test on rat and mouse skin: results with five skin carcinogens","volume":"513","author":"Nishikawa","year":"2002","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0885","series-title":"Environmental and Molecular Mutagenesis","article-title":"Testing the specificity of the in vivo rodent skin micronucleus assay as developed by Nishikawa et al., for chemicals negative in dermal carcinogenesis assays","author":"Gibson","year":"2004"},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0890","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/mutage\/geq056","article-title":"Development and characterisation of an in vitro photomicronucleus test using ex vivo human skin tissue","volume":"26","author":"Reus","year":"2011","journal-title":"Mutagenesis"},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0895","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2005.03.004","article-title":"The human epidermis models EpiSkin\u00ae, SkinEthic\u00ae and EpiDerm\u00ae: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport","volume":"60","author":"Netzlaff","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0900","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.taap.2005.10.003","article-title":"Effects of the differentiated keratinocyte phenotype on expression levels of CYP 1\u20134 family genes in human skin cells","volume":"213","author":"Du","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0905","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cbi.2004.08.006","article-title":"Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective","volume":"149","author":"Swanson","year":"2004","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0910","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.taap.2003.09.023","article-title":"Molecular pathways in dermatotoxicology","volume":"195","author":"Merk","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03602539008991444","article-title":"The cytochrome P450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals","volume":"22","author":"Ioannides","year":"1990","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0920","article-title":"Metabolically competent human skin models: activation and genotoxicity of benzo a pyrene","author":"Brinkmann","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0925","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mrgentox.2006.02.009","article-title":"Development of genotoxicity test procedures with Episkin\u00ae, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds?","volume":"606","author":"Flamand","year":"2006","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"5","key":"10.1016\/j.mrrev.2017.09.001_bib0930","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.tiv.2010.03.013","article-title":"Xenobiotic metabolism gene expression in the EpiDerm\u2122 in vitro 3D human epidermis model compared to human skin","volume":"24","author":"Hu","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.mrrev.2017.09.001_bib0935","first-page":"26","article-title":"EEC on the approximation of the laws of the Members States relating to cosmetic products","volume":"L66","author":"Union","year":"2003","journal-title":"Official J. Eur. Union"},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0940","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mrgentox.2006.04.016","article-title":"Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm\u2122)","volume":"607","author":"Curren","year":"2006","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0945","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/mutage\/get051","article-title":"Comet assay in reconstructed 3D human epidermal skin models\u2014investigation of intra-and inter-laboratory reproducibility with coded chemicals","volume":"28","author":"Reus","year":"2013","journal-title":"Mutagenesis"},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0950","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mrgentox.2008.12.004","article-title":"Further development of the EpiDerm\u2122 3D reconstructed human skin micronucleus (RSMN) assay","volume":"673","author":"Mun","year":"2009","journal-title":"Mutat. Res.\/Gen. Toxicol. Environ. Mutagen."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0955","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mrgentox.2013.08.001","article-title":"The reconstructed skin micronucleus assay in EpiDerm: reduction of false-positive results \u2014 a mechanistic study with epigallocatechin gallate","volume":"757","author":"Yuki","year":"2013","journal-title":"Mutat. Res."},{"issue":"2","key":"10.1016\/j.mrrev.2017.09.001_bib0960","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.taap.2012.03.019","article-title":"The use of ex vivo human skin tissue for genotoxicity testing","volume":"261","author":"Reus","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0965","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/cryo.1998.2076","article-title":"A comparative study of cryogenic lesions in organ-cultured human skin and in reconstituted human skin equivalent","volume":"36","author":"Capon","year":"1998","journal-title":"Cryobiology"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0970","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000066683","article-title":"Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol","volume":"15","author":"Dreher","year":"2002","journal-title":"Skin Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib0975","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000066680","article-title":"Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or \u03b1-tocopherol applied on human skin models or human skin ex vivo at finite doses","volume":"15","author":"Dreher","year":"2002","journal-title":"Skin Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0980","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaad.2005.04.007","article-title":"Self-treatment of a basal cell carcinoma with black and yellow salve","volume":"53","author":"Osswald","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.mrrev.2017.09.001_bib0985","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jep.2012.01.059","article-title":"Review of current and omics methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms","volume":"140","author":"Ouedraogo","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.mrrev.2017.09.001_bib0990","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2010.01131.x","article-title":"How accurate is in vitro prediction of carcinogenicity?","volume":"162","author":"Walmsley","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mrrev.2017.09.001_bib0995","series-title":"Chemical Induction of Cancer: Structural Bases and Biological Mechanisms","author":"Arcos","year":"2013"},{"issue":"1","key":"10.1016\/j.mrrev.2017.09.001_bib1000","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0378-1097(94)00180-4","article-title":"Induction of respiration-deficient mutants in Saccharomyces cerevisiae by chelerythrine","volume":"120","author":"Krivjansk\u00fd","year":"1994","journal-title":"FEMS Microbiol. Lett."}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574217300376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574217300376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T15:58:37Z","timestamp":1750867117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574217300376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":200,"alternative-id":["S1383574217300376"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2017.09.001","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinogenic potential of sanguinarine, a phytochemical used in \u2018therapeutic\u2019 black salve and mouthwash","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}